Raymond Anderson, Director at Raptor Pharmaceutical Corp (RPTP), sold 6,128 shares at $6.76 ($41K) on 2012-04-02, disclosed to the SEC on 2012-04-04.
Scheduled sale ($41k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.70 | 1,428 | $10K | 23.2% |
| 2 | $6.70 | 1,600 | $11K | 26.0% |
| 3 | $6.71 | 200 | $1K | 3.3% |
| 4 | $6.72 | 500 | $3K | 8.2% |
| 5 | $6.73 | 500 | $3K | 8.2% |
| 6 | $6.74 | 200 |
| $1K |
| 3.3% |
| 7 | $6.76 | 1,700 | $11K | 27.9% |
| Total | $6.72 avg | 6,128 | $41K | 100% |
| Filing → |
| RPTP | SELL | 2015-09-04 | $61K | — | Filing → |
| RPTP | SELL | 2015-09-02 | $101K | — | Filing → |
| RPTP | SELL | 2015-03-26 | $259K | — | Filing → |